Open access
Jan 2026
A Novel Attenuated NADC30‐Like PRRSV Vaccine Candidate Provides Cross‐Protection Against Homologous and Heterologous Viral Challenge
It is demonstrated that the attenuated strain AHFY‐F140 represents a promising vaccine candidate against both NADC30‐like and JXA1‐like PRRSV infections.
Hengjiao Zhang, Jiakai Zhao, Chengxin Zhang et al.
· Transboundary and Emerging D... · 0 citations